The Kable

The Kable

Friday Kable

💉 GSK’s RSV vaccine hits main goal in trials; Novartis hits a brick wall in court; Sanofi says sayonara to Japanese manufacturing

#194 | TRIPping over Covid extensions

Vinod's avatar
Vinod
Oct 14, 2022
∙ Paid

Hello and welcome to The Kable one last time this week, before we usher you into the weekend.

In news today, Novartis does to Ireland what it is doing to Switzerland: laying off people. 400 of them.

Maybe some of these redundant Irish workers could move to South Korea, where CDMO Samsung Biologics has started operations at the world's largest single bio-m…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 The Kable · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture